NUTRA PHARMA CORP. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)
NUTRA PHARMA CORP. (NPHC) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) of $2.45 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease · last filed 2026-08-19
- NUTRA PHARMA CORP. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2026-06-30 was $2.35M, a 5327.59% increase year-over-year.
- NUTRA PHARMA CORP. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2026-03-31 was $96.99K, a 125.85% increase year-over-year.
- NUTRA PHARMA CORP. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2025-12-31 was -$125.16K.
- NUTRA PHARMA CORP. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2025-09-30 was $43.88K.
- NUTRA PHARMA CORP. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2024 was $174.04K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | $2.45M 10-Q · filed 2026-08-19 | $2.32M derived: sum of 3 quarters · filed 2026-08-19 | $2.37M derived: sum of 4 quarters · filed 2026-08-19 |
| 2026-03-31 | $96.99K 10-Q · filed 2026-05-29 | -$28.17K derived: sum of 2 quarters · filed 2026-08-19 | $15.71K derived: sum of 3 quarters · filed 2026-08-19 | $59.05K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-12-31 | -$125.16K derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-19 | -$81.28K derived: sum of 2 quarters · filed 2026-08-19 | -$37.94K derived: sum of 3 quarters · filed 2026-08-19 | $5.00K 10-Q · filed 2026-08-19 |
| 2025-09-30 | $43.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-06 | $87.22K derived: sum of 2 quarters · filed 2026-04-06 | $130.17K 10-Q · filed 2026-04-06 | |
| 2025-06-30 | $43.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-03-25 | $86.28K 10-Q · filed 2026-03-25 | ||
| 2025-03-31 | $42.95K 10-Q · filed 2026-03-11 | |||
| 2024-12-31 | $174.04K 10-K · filed 2026-05-20 |